Andrew is the Chief Executive Officer and founder of MyMeds&Me. He is responsible for the delivery of product and company direction, ensuring strong customer experience for all MyMeds&Me clients and building a strong team of enthusiastic, industry specialists who are able to deliver high quality, SaaS products and services to life science customers. Andrew has held senior positions at GSK in the UK, USA and Asia Pacific and has extensive experience in driving significant change and innovation within global drug safety operations.
World Drug Safety USA 2017 - Day Two @ 15:50
Data value versus data volume: Simplifying AER capture across intake routes while addressing product risk management commitments
World Drug Safety USA 2017 - Plenary
- As volumes of AER’s continue to increase 10-20% year on year, how do we address the challenges of content quality and case processing efficiency?
- Can we adapt our methods to meet the needs of diverse product portfolios, allowing us to manage labelled AEs from established products and Events of Interest for products with Risk Management commitments appropriately?
- Join us as we look at how intelligent technology that provides harmonized intake solutions and configurable workflow is available today to solve these challenges
back to speakers